<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03832946</url>
  </required_header>
  <id_info>
    <org_study_id>GALACTIC-1</org_study_id>
    <secondary_id>2018-002664-73</secondary_id>
    <nct_id>NCT03832946</nct_id>
  </id_info>
  <brief_title>A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)</brief_title>
  <official_title>GALACTIC-1 -A Randomized, Double-blind, Multicentre, Parallel, Placebo-controlled Phase 2b Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of GB0139, an Inhaled Galectin-3 Inhibitor Administered Via a Dry Powder Inhaler Over 52 Weeks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Galecto Biotech AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Syneos Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>bioRASI, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Galecto Biotech AB</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF&#xD;
      (idiopathic pulmonary fibrosis) investigating the efficacy and safety of GB0139.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed to evaluate the efficacy and safety of GB0139, a galectin-3 inhibitor,&#xD;
      administered by dry powder inhalation over 52 weeks. GB0139, given once per day, will be&#xD;
      compared to placebo. GB0139 was previously known as TD139.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 19, 2019</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>All subjects eligible for the study will be randomised into one of the two treatment arms:&#xD;
A. GB0139 3 mg once a day B. Placebo once a day</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>This study is a double-blind study. The blinding will be maintained throughout the study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Annual rate of decline in Forced Vital Capacity (FVC)</measure>
    <time_frame>52 weeks</time_frame>
    <description>Efficacy of GB0139 as measured by the annual rate of decline in FVC expressed in mL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Absolute decline in FVC &gt;10%</measure>
    <time_frame>52 weeks</time_frame>
    <description>Proportion of subjects with an absolute decline from baseline in FVC (% predicted) of &gt; 10%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first hospitalization</measure>
    <time_frame>52 weeks</time_frame>
    <description>Time to first hospitalization (respiratory related, including acute exacerbation of IPF) expressed in days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to death</measure>
    <time_frame>52 weeks</time_frame>
    <description>Time to death from all-causes, respiratory-related causes and/or caused by IPF expressed in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Respiratory Related Quality of Life using the St. George's Respiratory Questionnaire (SGRQ)</measure>
    <time_frame>52 weeks</time_frame>
    <description>Change from baseline in the SGRQ total score. The SGRQ is a 50-item questionnaire split into three domains: symptoms, activity and impact. Weighting of both individual domains and the total score produces a range from 0 to 100, with higher scores indicating a poorer health-related quality of life.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Absolute decline in FVC &gt;5%</measure>
    <time_frame>52 weeks</time_frame>
    <description>Percentage of subjects with an absolute decline from baseline in FVC (% predicted) of &gt; 5%</description>
  </other_outcome>
  <other_outcome>
    <measure>6-minute walk test (6MWT) distance</measure>
    <time_frame>52 weeks</time_frame>
    <description>Change from baseline in distance walked (metres) over 6 minutes</description>
  </other_outcome>
  <other_outcome>
    <measure>Diffusion capacity of the lung for carbon monoxide (DLCO)</measure>
    <time_frame>52 weeks</time_frame>
    <description>Change from baseline in DLCO, corrected for Hemaglobin (mmol/min/kPa)</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessment of Dyspnea using the University of California San Diego - Shortness of Breath Questionnaire (UCSD - SOBQ)</measure>
    <time_frame>Weeks 12, 26 and 52</time_frame>
    <description>Change from baseline in UCSD - SOBQ Scored from 0-120 where a higher score indicates worse dyspnea</description>
  </other_outcome>
  <other_outcome>
    <measure>Assessment of Health Related Quality of Life (HRQoL) using the Short-Form 36-Item Health Survey (SF-36)</measure>
    <time_frame>Weeks 12, 26 and 52</time_frame>
    <description>The Medical Outcomes SF-36 It is a self-administered questionnaire of 36-items measuring eight dimensions of general HRQoL: physical functioning (10 items), role limitation due to physical health problems (4 items), bodily pain (2 items), general health perceptions (5 items), vitality (4 items), social functioning (2 items), role limitations due to emotional problems (3 items), and general mental health (5 items). In addition to scores for individual dimensions, two summary scores assessing physical and mental dimensions of health and well-being can also be calculated: Physical Component Summary (PCS) score and the Mental Component Summary (MCS) score, respectively. A higher score indicates a more favourable state of health</description>
  </other_outcome>
  <other_outcome>
    <measure>Frequency of Adverse Events (AE) or Serious Adverse Events (SAE)</measure>
    <time_frame>52 weeks</time_frame>
    <description>Percentage of subjects with Adverse Events (AE) or Serious Adverse Events (SAE)</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to hospitalization</measure>
    <time_frame>52 weeks</time_frame>
    <description>Time in days to first hospitalization from all causes</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to hospitalization</measure>
    <time_frame>52 weeks</time_frame>
    <description>Time in days to first hospitalization (IPF related, including acute exacerbation of IPF)</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to respiratory related death</measure>
    <time_frame>52 weeks</time_frame>
    <description>Time in days to death from respiratory related causes (including IPF)</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to initiation of pirfenidone or nintedanib treatment</measure>
    <time_frame>52 weeks</time_frame>
    <description>Time in days to initiation of pirfenidone or nintedanib treatment in subjects not treated with pirfenidone or nintedanib at time of enrolment</description>
  </other_outcome>
  <other_outcome>
    <measure>Annual rate of decline in FVC in subjects never treated with pirfenidone or nintedanib</measure>
    <time_frame>52 weeks</time_frame>
    <description>Change in FVC expressed in mL for subjects who have never been treated with pirfenidone or nintedanib</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Idiopathic Pulmonary Fibrosis (IPF)</condition>
  <arm_group>
    <arm_group_label>A. GB0139 3 mg once a day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inhalation of GB0139</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B. Placebo once a day</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Inhalation of Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GB0139</intervention_name>
    <description>GB0139 is a galectin-3 inhibitor designed to modulate the fibrogenic response to tissue injury. It is administered as inhalation once a day.</description>
    <arm_group_label>A. GB0139 3 mg once a day</arm_group_label>
    <other_name>TD139</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo is administered as inhalation once a day</description>
    <arm_group_label>B. Placebo once a day</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male and female subjects aged ≥ 40 years of age with a diagnosis of IPF established&#xD;
             during the previous five years according to ATS/ERS/Fleischner criteria.&#xD;
&#xD;
          2. Lung function parameters as follows:&#xD;
&#xD;
               1. Forced Vital Capacity (FVC) &gt; 45% of the predicted value at screening&#xD;
&#xD;
               2. Diffusion lung capacity for carbon monoxide (DLCO) (corrected for Hb) of 30% to&#xD;
                  79% of the predicted value at screening&#xD;
&#xD;
          3. Subjects who currently are not being treated with nintedanib or pirfenidone; or cannot&#xD;
             tolerate nintedanib or pirfenidone&#xD;
&#xD;
          4. Subjects must sign and date a written, IRB/EC approved informed consent form and any&#xD;
             required authorization prior to initiation of any study procedures.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Currently has significant airways obstruction: Forced Expiratory Volume in 1 s&#xD;
             (FEV1)/Forced Vital Capacity (FVC) ratio of &lt; 0.7 at screening.&#xD;
&#xD;
          2. Has clinical evidence of active infection, including, but not limited to, bronchitis,&#xD;
             pneumonia, sinusitis, urinary tract infection, and cellulitis.&#xD;
&#xD;
          3. Has a history of malignancy within the last 2 years with the exception of basal cell&#xD;
             carcinoma, chronic lymphocytic leukaemia (under observation) and prostate cancer&#xD;
             requiring anti-androgens, localised treatment (minor surgery, radiotherapy) and/or&#xD;
             managed by observation.&#xD;
&#xD;
          4. Has any condition other than IPF that, in the opinion of the investigator, is likely&#xD;
             to result in the death of the subject within the next 2 years.&#xD;
&#xD;
          5. Presence of other disease that may interfere with testing procedures or in the&#xD;
             judgement of the Investigator may interfere with trial participation or may put the&#xD;
             patient at risk when participating in this trial.&#xD;
&#xD;
          6. Is likely to receive lung transplantation within the next 12 months.&#xD;
&#xD;
          7. Currently receiving nintedanib, pirfenidone, high dose corticosteroid, cytotoxic&#xD;
             (e.g., chlorambucil, azathioprine, cyclophosphamide, methotrexate), vasodilator&#xD;
             therapy for pulmonary hypertension (e.g., bosentan). A current dose of less than or&#xD;
             equal to 15 mg/day of prednisone or its equivalent is acceptable if the dose is&#xD;
             anticipated to remain stable during the study.&#xD;
&#xD;
          8. Prior use of GB0139 (also called TD139) or previously randomized in GALACTIC-1.&#xD;
&#xD;
          9. Prior use of nintedanib or pirfenidone within 7 days of initiation of screening.&#xD;
&#xD;
         10. Prior use of investigational drugs within 30 days (or 5 half-lives, whichever is&#xD;
             longer) of initiation of screening.&#xD;
&#xD;
         11. Participating in another clinical trial, either interventional or observational.&#xD;
&#xD;
         12. Has a history of unstable or deteriorating cardiac or pulmonary disease (other than&#xD;
             IPF) within the previous six months, including, but not limited to, the following:&#xD;
&#xD;
               1. Unstable angina pectoris or myocardial infarction, or percutaneous coronary&#xD;
                  intervention within the last 6 months&#xD;
&#xD;
               2. Congestive heart failure requiring hospitalization&#xD;
&#xD;
               3. Uncontrolled clinically significant arrhythmias&#xD;
&#xD;
         13. If female, the subject is pregnant or lactating or intending to become pregnant before&#xD;
             participating in this study during the study and within (5 half- lives plus 30 days)&#xD;
             after last dose of the study drug; or intending to donate ova during such time period.&#xD;
&#xD;
         14. Woman considered to be of childbearing potential who do not use highly effective birth&#xD;
             control methods during the study.&#xD;
&#xD;
         15. Hypersensitivity to the active substance (TD139/GB0139) or the excipient (lactose).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toby Maher, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keck Medicine of USC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chief Medical Officer, MB, ChB</last_name>
    <phone>+442036911677</phone>
    <email>Clinicaltrials@galecto.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>SEC Clinical Research</name>
      <address>
        <city>Andalusia</city>
        <state>Alabama</state>
        <zip>36420-5310</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jasper Summit Research, LLC Pulmonary &amp; Sleep Associates</name>
      <address>
        <city>Jasper</city>
        <state>Alabama</state>
        <zip>35501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Westerman, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Palmtree Clinical Research Inc</name>
      <address>
        <city>Palm Springs</city>
        <state>California</state>
        <zip>92262-4871</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Paradigm Research</name>
      <address>
        <city>Redding</city>
        <state>California</state>
        <zip>96001-0172</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yale University Scholl of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520-8057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Health Shands Hospital</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Harmony Medical Research Institute, Inc</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Fernandez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Advanced Research for Health Improvement</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Broward Research Center</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustavo Echarte, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Avanza Medical Research Center</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Bercz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Coastal Pulmonary Critical Care PLC</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Warren Abel, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital/Uni Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debabrata Bandyopadhyay, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Piedmont Healthcare Pulmonary and Critical Care Research</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Emory Clinic</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Srihari Veeraraghaven, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>DC Research Works</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060-7297</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Binu George, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>97232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rade Tomic, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>LaPorte County Institute for Clinical Research</name>
      <address>
        <city>Michigan City</city>
        <state>Indiana</state>
        <zip>46360-9330</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Hamblin, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Louisville Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Britt, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Harvard Medical School -Brigham and Womens Hospital (BWH)</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Lung Research Center LLC</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neil Ettinger, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03766</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pulmonlx LLC</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45276</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nishant Gupta, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232-2650</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Centre at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Sciences Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodeo Abrencillo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Diagnostics Research Group</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Charles, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Utah Health Scieces Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>TPMG Clinical Research</name>
      <address>
        <city>Williamsburg</city>
        <state>Virginia</state>
        <zip>23188</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vijay Subramaniam, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lung Research QLD</name>
      <address>
        <city>Chermside</city>
        <state>Queensland</state>
        <zip>4032</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Chambers, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute for Respiratory Health Sir Charles Gairdner Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fiona Lake, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>TrialsWest</name>
      <address>
        <city>Spearwood</city>
        <state>Western Australia</state>
        <zip>6163</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Bremner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires St-Luc</name>
      <address>
        <city>Louvain-la-Neuve</city>
        <state>Wallon Region</state>
        <zip>1348</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UZ Antwerp</name>
      <address>
        <city>Antwerp</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CUB Hopital Erasme</name>
      <address>
        <city>Brussels</city>
        <zip>1400</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UZ Leuven- Campus Gasthuisberg</name>
      <address>
        <city>Brussels</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU UCL Namur site Godinne</name>
      <address>
        <city>Namur</city>
        <zip>5000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Firestone Institute for Respiratory Health</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Kolb, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr Anees Medicine Professional Corporation</name>
      <address>
        <city>Windsor</city>
        <state>Ontario</state>
        <zip>N8X 1T3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Syed Anees, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr Dhar Medical Practice</name>
      <address>
        <city>Windsor</city>
        <state>Ontario</state>
        <zip>N8X 5A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anil Dhar, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toronto General Hosp Research Inst</name>
      <address>
        <city>Toronto</city>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shane Shapera, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Hopitaux Universitaires Paris-Seine-Saint-Denis-Hopital Avicenne</name>
      <address>
        <city>Bobigny</city>
        <zip>93000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hilario Nunes, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Lille - Hopital Calmette</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lidwine Wemeau, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP - Hopital Europen Georges-Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Israel-Biet, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Bichat</name>
      <address>
        <city>Paris</city>
        <zip>75877</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Crestani, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Rennes Hopital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephane Jouneau, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de la Réunion Site SUD (Terre Sainte)</name>
      <address>
        <city>Saint Pierre</city>
        <zip>97410</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanny Jean, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de la Réunion- Site Félix Guyon</name>
      <address>
        <city>Saint-Pierre</city>
        <zip>97410</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Allou, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopitaux Universitaires de Strasborg Service de Pneumologie Nouvel Hopital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain Kessler, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Rgional et Universitaire - Hopital Bretonneau</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvain Marchand Adam, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CIMS Studienzentrum Bamberg GmbH</name>
      <address>
        <city>Bamberg</city>
        <zip>96049</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joachim Kirschner, Joachim, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Donaustauf</name>
      <address>
        <city>Donaustauf</city>
        <zip>93093</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Pfeifer, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ruhrlandklinik Essen</name>
      <address>
        <city>Essen</city>
        <zip>45239</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Bonella, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Leipzig Klinik und Poliklinik für Onkologie, Gastroenterologie, Hepatologie, P</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hubert Wirtz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>POIS Leipzig GbR</name>
      <address>
        <city>Leipzig</city>
        <zip>04357</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Gessner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Grossadern der Ludwig-Maximilians-Universitaet Muenchen</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikolaus Kneidinger, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neville Berkman, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Meir Medical Center</name>
      <address>
        <city>Kefar Sava</city>
        <zip>44281</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Shitrit, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pulmonary Institute Rabin Medical Center</name>
      <address>
        <city>Petah Tikva</city>
        <zip>4941492</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mordechai Kramer, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Segel, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center</name>
      <address>
        <city>Reẖovot</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gershon Fink, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University-Hospital Policlinico Vittorio Emanuele</name>
      <address>
        <city>Catania</city>
        <zip>95123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giuseppe Clinica Malattie dell Apparato Respiratorio</name>
      <address>
        <city>MIlan</city>
        <zip>20123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital of Mondena-AOU - Policlinico di Modena</name>
      <address>
        <city>Modena</city>
        <zip>41124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>A.O. Dei Colli OSPEDALE MONALDI</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale GB Morgagni</name>
      <address>
        <city>Padova</city>
        <zip>35100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Istituto Mediterraneo Trapianti e Terapia Alta Specializzazione (ISMETT)</name>
      <address>
        <city>Palermo</city>
        <zip>90127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Senese</name>
      <address>
        <city>Siena</city>
        <zip>53100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>AOU Città della Salute e della Scienza, PO Molinette</name>
      <address>
        <city>Turin</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny Nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi</name>
      <address>
        <city>Łódź</city>
        <state>Lodz</state>
        <zip>90-153</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wojciech Piotrowski, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instytut Gruzlicy i Chorob Pluc, I Klinika Chorob Pluc</name>
      <address>
        <city>Warszawa</city>
        <state>Mazovia</state>
        <zip>01-138</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katarzyna Lewandowska, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oddział Kliniczny Pulmonologii i Alergologii Szpitala Uniwersyteckiego w Krakowie</name>
      <address>
        <city>Kraków</city>
        <state>Małopolskie</state>
        <zip>30688</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krzysztof Sładek, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinika Alergologii Pneumonologii</name>
      <address>
        <city>Gdańsk</city>
        <state>Pomerania</state>
        <zip>80-214</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alicja Sieminska, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu</name>
      <address>
        <city>Poznań</city>
        <zip>60-569</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Halina Batura-Gabryel, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Arias-Guillen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Quiron Madrid</name>
      <address>
        <city>Pozuelo De Alarcón</city>
        <state>Madrid</state>
        <zip>28223</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Echave, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinica Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Roldan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacobo Sellares, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diego Castillo Villagas, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>8035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Villar, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asuncion Nieto, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Estrella Fernandez Fabrellas, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Devon and Exeter Hospital</name>
      <address>
        <city>Exeter</city>
        <state>Devon</state>
        <zip>EX2 5DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Burdem, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Molyneaux, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wythenshawe Hospital</name>
      <address>
        <city>Manchester</city>
        <state>Greater Manchester</state>
        <zip>M23 9LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nazia Chaudhuri, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton NHS Foundation Trust</name>
      <address>
        <city>Southampton</city>
        <state>Hampshire</state>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Fletcher, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Glenfield Hospital</name>
      <address>
        <city>Leicester</city>
        <state>Leicestershire</state>
        <zip>LE3 9QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bibek Gooptu, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aintree Unversity Hospital NHS Foundation Trust</name>
      <address>
        <city>Liverpool</city>
        <state>Merseyside</state>
        <zip>L9 7AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Spencer, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Newcastle Royal Victoria Infirmary</name>
      <address>
        <city>Newcastle Upon Tyne</city>
        <state>Newcastle</state>
        <zip>NE1 4LP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ian Forrest, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nottingham City Hospital</name>
      <address>
        <city>Nottingham</city>
        <state>Nottinghamshire</state>
        <zip>NG5 1PB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gauri Saini, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sheffield Teaching Hospitals NHS Foundation Trust - Royal Hallamshire Hospital (RHH)</name>
      <address>
        <city>Sheffield</city>
        <state>South Yorkshire</state>
        <zip>S5 7AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Bianchi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Birmingham Heartlands Hospital</name>
      <address>
        <city>Birmingham</city>
        <state>West Midlands</state>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gareth Walters, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Research Centre - Respiratory North Bristol NHS Trust Southmead Hospital</name>
      <address>
        <city>Bristol</city>
        <zip>BS10 5NB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huzaifa Adamali, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikhil Hirani, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 4, 2019</study_first_submitted>
  <study_first_submitted_qc>February 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 6, 2019</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TD139</keyword>
  <keyword>Idiopathic pulmonary fibrosis</keyword>
  <keyword>Galectin-3 inhibitor</keyword>
  <keyword>GB0139</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

